Mechanistic results revealed that TMZ-resistant GBM cells could reshape the TME and promote tumor chemoresistance by secreting exosome-derived SBF2-AS1 into TMZ-sensitive GBM cells and promoting XRCC4 expression through binding to miR-151a-3p [99]. Here, XRCC4 is linked to glioblastoma.